Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Lyell Immunopharma, Inc. has filed 330 SEC EDGAR filings since 20 Mar 2020

SEC filing history

Showing 76-100 of 330 matching filings.

Per page
25
Current page
4
EFFECT File 333-289539

EFFECT filing

Filing date
15 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
13 Aug 2025
Reporting date
11 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
13 Aug 2025
Reporting date
11 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
13 Aug 2025
Reporting date
11 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
13 Aug 2025
Reporting date
11 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
13 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-289539

UPLOAD filing

Filing date
13 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-93402

SCHEDULE 13G filing

Filing date
01 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-288769

424B5

Filing date
31 Jul 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-288769

EFFECT filing

Filing date
30 Jul 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
29 Jul 2025
Reporting date
25 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
29 Jul 2025
Reporting date
25 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
28 Jul 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-288769

UPLOAD filing

Filing date
23 Jul 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Jun 2025
Reporting date
09 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Jun 2025
Reporting date
09 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Jun 2025
Reporting date
09 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
11 Jun 2025
Reporting date
09 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .